Please login to the form below

Not currently logged in
Email:
Password:

MSD

This page shows the latest MSD news and features for those working in and with pharma, biotech and healthcare.

Keytruda shows significant and meaningfully improvement in kidney cancer

Keytruda shows significant and meaningfully improvement in kidney cancer

Merck announces results from its phase 3 KEYNOTE-564 trial. Merck, known as MSD outside the United States and Canada, yesterday announced results from its pivotal phase 3 KEYNOTE-564 trial

Latest news

More from news
Approximately 68 fully matching, plus 382 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 34 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 50 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics